Abstract
An accurate staging classification, which is essential for good management of any cancer, should highlight the major factors which influence survival. Cancer of the colon and rectum spreads in a predictable fashion through successive layers of the intestinal wall and spreads to lymph nodes or distant organs. In 1932 Dukes used this pattern in tumour spread as the basis for the staging classification of colorectal cancer, which bears his name. He reported the results of 215 patients with operable rectal cancer and staged them into 3 categories—A, B and C—according to the extent of bowel wall penetration by tumour and the presence or absence of lymph node metastases. A few years later Gabriel et al. (1) modified the classification by subdividing stage C (positive lymph nodes) into types 1 and 2 depending on the level of lymph node involvement. Although the Dukes’ classification originally was applied to carcinoma of the rectum, it was implied what the staging could also be used for colonic tumours.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gabriel WB, Dukes CE and Bussey HJR: Lymphatic spread in cancer of the rectum. Br J Surg 23: 395–413, 1935.
Kirklin JW, Dockerty MB and Waugh JM: The role of the peritoneal reflection in the prognosis of carcinoma of the rectum and sigmoid colon. Surg Gynecol Obstet 88: 326–331, 1949.
Astler VB and Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139: 846–852, 1954.
Goligher JC: The Dukes A, B and C categorization of the extent of spread of carcinomas of the rectum. Surg Gynecol Obstet 143: 793–794, 1976.
Beart RW, van Heerden JA and Beahrs OH: Evolution in the pathologic staging of carcinoma of the colon. Surg Gynecol Obstet 146: 257–259, 1978.
Dukes CE and Bussey HJR: The spread of rectal cancer and its effect on prognosis. Br J Cancer 12: 309–320, 1958.
Gunderson LI and Sosin H: Areas of failure found at reoperation (second or symptomatic look) following ‘curative surgery’ for adenocarcinoma of the rectum. Cancer 34: 1278–1292, 1974.
Wood CB: Tumour Staging. Boerhaave International Course on colorectal cancer, University of Leiden. Conference proceedings p 11–16.
Moossa AR, Ree PC, Marks JE, Levin B, Platz CE and Skinner DB: Factors influencing local recurrence after abdomino-perineal section for cancer of the rectum and rectosigmoid. Br J Surg 62: 727–730, 1975.
Godwin JD and Brown CC: Some prognostic factors in survival of patients with cancer of the colon and rectum. J Chronic Dis 28: 441–454, 1975.
Wood CB, Gillis CR, Hole D and Blumgart LH: Prospective study of the natural history of patients with synchronous liver metastases from colorectal cancer, 1980 (in preparation).
Spratt JS, Jr and Spjut H: Prevalence and prognosis of individual clinical and pathological variables associated with colorectal carcinoma. Cancer 29: 1976–1985, 1967.
McLaughlin CW, Jr, Coe JD and Adwers JR: A thirty year study of breast cancer in a consecutive series of private patients. Is axillary nodal study a valuable index in prognosis. Am J Surg 136: 250–253, 1978.
Broders AC: Grading of carcinoma. Minnesota Med 8: 726–730, 1925.
Dukes CW: Cancer of rectum; an analysis of 1000 cases. J Path Bacteriol 50: 527–539, 1940.
Sunderland DA: The significance of vein invasion by cancer of the rectum and sigmoid; a microscopic study of 210 cases. Cancer 2: 429–437, 1949.
Dunning EJ, Jones TE and Hazard JB: Carcinoma of the rectum. A study of factors influencing survival following combined abdomino-perineal resection of the rectum. Ann Surg 133: 166–173, 1951.
Copeland EM, Miller LD and Jones RS: Prognostic factors in carcinoma of the colon and rectum. Am J Surg 116: 875–881, 1968.
Buckwalter JA, Jr and Kent TH: Prognosis and surgical pathology of carcinoma of the colon. Surg Gynecol Obstet 136: 465–472, 1973.
Grinnell RS: The grading and prognosis of carcinoma of the colon and rectum. Ann Surg 109: 500–533, 1939.
Qualheim RE and Gall EA: Is histologic grading of colon carcinoma a valid procedure? Arch Pathol 56: 466–472, 1953.
Bengmark S and Hafstrom L: The natural history of primary and secondary malignant tumours of the liver. Cancer 23: 198–202, 1969.
Brown CE and Warren S: Visceral metastasis from rectal carcinoma. Surg Gynecol Obstet 66:611–621, 1938.
Dionne L: The pattern of blood-born metastasis from carcinoma of rectum. Cancer 18: 775–781, 1965.
Dukes CE: The surgical pathology of rectal cancer. Proc Roy Soc Med 37: 131–144, 1944.
Grinnell RS: The lymphatic and venous spread of carcinoma of the rectum. Ann Surg 11: 200–216, 1942.
Talbot IC, Ritchie S, Leighton M, Hughes AJ, Bussey HJR and Morson BC: The clinical significance of invasion of veins by rectal cancer. Br J Surg, 1980 (in press).
Oxley EM and Ellis H: Prognosis of carcinoma of the large bowel in the presence of liver metastases. Br J Surg 56: 149–152, 1969.
Wood CB, Gillis CR and Blumgart LH: A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2: 285–288, 1976.
Jaffe BM, Donegan WL, Watson F and Spratt JS, Jr: Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 127: 1–11, 1968.
Nielsen J, Balslev I and Jensen HE: Carcinoma of the colon with liver metastases. Operative indications and prognosis. Acta Chirurgica Scand 137: 463–465, 1971.
Ariel IM: Systemic 5-fluorouracil in hepatic metastases from primary colon or rectal cancer. NY State J Med 12: 1041–1044, 1972.
Watkins E, Jr, Khazei AM and Nahra KS: Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gynecol Obstet 130: 581–605, 1970.
Taylor I: Cytotoxic perfusion for colorectal liver metastases. Br J Surg 65: 109–114, 1978.
Murray-Lyon IM, Parsons VA, Blendis LM, Dawson JL, Rake MO, Laws JW and Williams R: Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs. Lancet ii: 172–175, 1970.
Cady B and Oberfield RA: Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg 127: 220–227, 1974.
Foster JH: Survival after liver resection for cancer. Cancer 26: 493–502, 1970.
Wilson SM and Adson MA: Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 111: 330–334, 1976.
Wanebo HJ, Semoglou C, Attiyeh F and Stearns MJ, Jr: Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 135: 81–85, 1978a.
Adson MA and Sheedy PF: Resection of primary hepatic malignant lesions. Arch Surg 108: 599–603, 1974.
Blumgart LH, Drury JK and Wood CB: Hepatic resection for trauma, tumour and biliary obstruction. Br J Surg 66: 762–769, 1979.
Gold P and Freedman SO: Specific carcinoembryonic antigens of the human digestive system. J Experim Med 122: 467–481, 1965.
Reynoso G, Chu TM, Holyoke D, Cohen E, Nemoto T, Wang J-J, Chuang J, Guinan P and Murphy GP: Carcinoembryonic antigen in patients with different cancers. JAMA 220: 361–365, 1972.
Booth SN, King JPG, Leonard JC and Dykes PW: Serum carcinoembryonic antigen in clinical disorders. Gut 14: 794–799, 1973.
Costanza ME, Das S, Nathanson L, Rule A and Schwartz RS: Carcinoembryonic antigen. Report of a screening study. Cancer 33: 583–590, 1974.
Hansen HJ, Snyder JJ, Miller E, Vandevoorde JP, Miller ON, Hines LR and Burns JJ: Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pat hoI 5: 139–147, 1974.
Dhar P, Moore T, Zamcheck N and Kupchick HA: Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. JAMA 221: 31–35, 1972.
Zamcheck N: The present status of CEA in diagnosis, prognosis and evaluation of therapy. Cancer 36: 2460–2468, 1975.
Minton JP, James KK, Hurtubise PE, Rinker L, Joyce S and Martin EW, Jr: The use of serial carcinoembryonic antigen determinations to predict recurrence of carcinoma of the colon and the time for second-look operation. Surg Gynecol Obstet 147: 208–210, 1978.
Mackay AM, Patel S, Carter U, Laurence DJR, Cooper EH and Neville AM: Role of serial plasma CEA assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J 4: 382–385, 1974.
Sorokin JJ, Sugarbaker PH, Zamcheck N, Pisick M, Kupchik HZ and Moore FD: Serial carcinoembryonic antigen assays. Use in detection of cancer recurrence. JAMA 228: 49–53, 1974.
Martin EW, James KK, Hurtubise PE, Catalano P and Minton JP: The use of CEA as an early indicator for gastrointestinal tumour recurrence and second-look procedures. Cancer 39: 440–446, 1977.
Staab HJ, Anderer FA, Stumpf E and Fischer R: Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. Am J Surg 136: 322–327, 1978.
Wood CB, Ratcliffe JG, Burt TW, Malcolm AJH and Blumgart LH: The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg 67: 46–48. 1980.
Go, VLW: Carcinoembryonic antigen. Clinical application. Cancer 37: 562–566, 1976.
Moertell CG, Schutt AJ and Go VLW: Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection. JAMA 239: 1065–1066, 1978.
Lo Gerfo P and Herter FP: Carcinoembryonic antigen and prognosis in patients with colon cancer. Ann Surg 181: 81–83, 1975.
Herrera MA, Chu TM and Holyoke D: Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg 183: 5–9, 1976.
Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwarts MR and Oettgen HF: Preoperative carcinoembryonic antigen levels as a prognostic indicator in colorectal cancer. New Engl J Med 229: 448–451, 1978b.
Laurence DJR, Stevens U, Bettleheim R, Darcy D, Leese C, Tuberville C, Alexander P, Johns EW and Munro Neville A: Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary and bronchial carcinoma. Br Med J 3: 605–609, 1972.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Martinus Nijhoff Publishers by, The Hague/Boston/London
About this chapter
Cite this chapter
Wood, C.B. (1980). Prognostic Factors in Staging of Colorectal Cancer. In: Welvaart, K., Blumgart, L.H., Kreuning, J. (eds) Colorectal Cancer. Boerhaave Series for Postgraduate Medical Education, vol 18. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-9158-3_4
Download citation
DOI: https://doi.org/10.1007/978-94-009-9158-3_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-9160-6
Online ISBN: 978-94-009-9158-3
eBook Packages: Springer Book Archive